How Medical Spas Are Valued in Orange County

YW Capital Advisors — California business brokerage and real estate transactions.

Medical spas in Orange County trade at 2.5x-7x earnings. Learn medspa valuation multiples, SBA financing, and due diligence for buyers in Irvine and Newport Beach.

Medical spas in Orange County trade at 2.5x to 7x earnings depending on size and membership revenue - here is exactly how the math works and what moves the multiple.

Published 2026-10-19 by YW Capital Advisors

Orange County has one of the highest concentrations of medical spas in California, driven by the affluent demographics of Newport Beach, Irvine, and Laguna Beach. These businesses - offering Botox, dermal fillers, laser skin resurfacing, body contouring, and IV therapy - have grown from niche to mainstream over the past decade. A well-run Orange County medspa generating $400,000 to $600,000 in seller's discretionary earnings (SDE) is now a serious acquisition target, attracting both individual buyers and private equity-backed consolidators. Understanding how these practices are valued is the first step toward buying one intelligently.

This guide walks through valuation mechanics, the key factors that move multiples up or down, SBA financing specifics, and the due diligence items unique to medspa acquisitions. The numbers here reflect actual 2026 transaction data, not generic industry averages.

What Makes a Medical Spa Different from a Day Spa

The defining feature of a medical spa is physician oversight. California law requires a licensed physician to serve as medical director, owning or co-owning the practice and supervising aesthetic treatments including Botox injections, laser procedures, and chemical peels. This structure creates both complexity and value: complexity because ownership may require a medical license or a formal management services organization (MSO) structure, and value because the medical director requirement is a barrier to entry that supports pricing power. A traditional day spa operates on cosmetology licensing alone and cannot legally offer injectable treatments.

When evaluating a medspa for acquisition, confirm the medical director arrangement early. Whether the physician is a passive signatory or an active provider shapes both the practice risk profile and its transition timeline. A medical director who sees patients three days a week and wants to retire is a very different situation than a passive signatory who provides oversight remotely - and lenders treat these scenarios differently when underwriting an SBA loan.

How Medspas Are Valued: The Multiples That Matter

Medspas are valued on a multiple of SDE for smaller practices or adjusted EBITDA for multi-provider groups. According to FOCUS Investment Banking's 2026 medspa valuation dashboard, single-provider practices with under $500,000 in SDE typically trade at 2.5x to 3.5x. Multi-provider groups with $500,000 to $1,000,000 in SDE trade at 3.5x to 5.0x. As earnings scale above $1 million in adjusted EBITDA, multiples move to 5x to 7x for lower-middle-market practices. The jump at the $1 million threshold reflects reduced key-person risk, documented systems, and a diversified patient base - qualities that make a practice financeable and transferable.

To run the math on a real scenario: a single-provider Newport Beach medspa with $420,000 in SDE, strong Google reviews, and 35% of revenue from monthly memberships might price at 3.25x to 3.75x SDE, or $1.37 million to $1.58 million. A three-provider Irvine group with $1.2 million in adjusted EBITDA could command 5.5x to 6.5x, or $6.6 million to $7.8 million. These ranges assume clean books, a transferable lease, and a medical director who remains through transition.

What Drives the Multiple Up or Down

Membership revenue is the single biggest positive lever in medspa valuation. Practices where 30% to 40% of revenue comes from monthly membership programs - typically $99 to $199 per month for a package of treatments - command a 0.5x to 1.0x premium over comparable non-membership peers. The logic is simple: recurring revenue reduces volatility and makes forward cash flows more predictable for both the buyer and the SBA lender reviewing the deal. In competitive markets like Irvine and Newport Beach, practices with active membership programs also tend to have lower patient acquisition costs, which supports margin.

On the negative side, key-person concentration is the most common discount factor. If a single nurse injector or the medical director personally performs 40% or more of revenue-generating treatments, the buyer is acquiring a fragile practice that depends on one person not leaving. Practices with a Google rating below 4.5 stars are penalized by 0.25x to 0.75x in valuation - in an Orange County market where patients have dozens of choices within ten miles, reputation scores directly affect new patient acquisition cost. Equipment dependency also reduces multiples: a practice built around a single cosmetic laser trades at lower multiples than a full-service provider with a diversified treatment menu, because one equipment failure or a technology shift can materially impair revenue overnight.

SBA Financing for a MedSpa Acquisition

Most medspa acquisitions under $5 million are financed using SBA 7(a) loans, which allow buyers to put as little as 10% down on the purchase price. As of early 2026, variable-rate SBA 7(a) loans over $350,000 carry a maximum rate of prime plus 3.0%, which puts the current cap at approximately 9.75% based on a prime rate of 6.75%. On a $1.5 million acquisition with 10% down and a $1.35 million loan at a 10-year amortization, monthly debt service runs approximately $17,600 - requiring roughly $211,000 in annual payments. At a purchase price of 3.0x SDE on $420,000 in earnings, the practice generates enough cash flow to cover that service with meaningful income left for the owner.

SBA lenders underwrite medspas with extra scrutiny because of the medical director regulatory overlay. Buyers with no clinical background can absolutely acquire a medspa - but they will need to demonstrate a credible plan for medical oversight that does not depend on a single departing physician. In practice, this means either retaining the current medical director on a multi-year agreement or engaging a physician management group before underwriting begins. Some lenders require the medical director arrangement to be contractually locked in for the full loan term as a condition of approval.

Due Diligence: What to Scrutinize Before You Close

Medspa due diligence has several layers that a standard retail business acquisition does not. Start with revenue verification: request point-of-sale reports, membership management software exports, and merchant processing statements for at least 24 months. Ask for a breakdown by treatment category - what percentage comes from injectables (Botox, fillers), what percentage from laser or device treatments, and what percentage from skincare retail. A practice where 70% of revenue is Botox and fillers is more exposed to a key-provider departure than one with a diversified treatment mix across multiple service lines.

Review the equipment roster and confirm ownership status. Many medspas lease high-ticket lasers through device company programs, which can inflate apparent revenue per treatment while hiding a significant monthly obligation. Confirm that all treatments being offered fall within the scope of the medical director's licensure and have been performed under proper supervision protocols. California's Medical Board periodically investigates medspas where the medical director is a passive signatory with no regular presence in the office - that is a compliance liability you inherit at closing, and it can surface during lender underwriting as well. Requesting the past two years of Medical Board correspondence and any complaint history is standard practice in a well-run medspa transaction.

Timing Your Entry into the OC MedSpa Market

Orange County's medspa market has matured significantly over the past five years. First-generation founders who launched practices in 2015 to 2019 are now reaching the point where succession planning becomes relevant, and PE-backed consolidators have absorbed many of the larger regional groups. What remains for individual buyers is largely the sub-$2 million SDE segment: single-provider practices and small two-to-three provider groups in cities like Costa Mesa, Fountain Valley, and Anaheim where rents are lower than Newport Beach or Laguna Beach but patient demographics remain strong.

The window for individual buyers is narrowing as private equity moves down-market in search of platform acquisitions. A medspa generating $350,000 to $700,000 in SDE today is a viable individual acquisition; that same practice in two to three years may be absorbed into a regional group at a price that prices out a single buyer. If you are considering entering this space, the current rate environment and available inventory in Southern California make 2026 a more favorable entry point than many expect.

YW Capital Advisors works with buyers and sellers of medical spas across Orange County, from single-provider practices in Costa Mesa to multi-location groups serving patients throughout Irvine and Newport Beach. We understand the regulatory structure, the valuation mechanics, and the SBA lending requirements specific to this sector. If you are considering selling your medspa or acquiring one in Southern California, contact YW Capital Advisors for a confidential consultation and a current market valuation.

Contact

LLM-friendly site summary · Full LLM summary · XML sitemap